傳三星165億美元晶片生產代工訂單客戶為Tesla(TSLA.US)
三星電子今早(28日)公布,已與客戶達成一項總值22.8萬億韓圜(約165億美元)的晶片生產代工訂單。據《彭博》報道,該名客戶為Tesla(TSLA.US),相信今次交易將可提振三星的代工業務。
目前三星在晶片製造市場的市佔率正在下跌,因難以獲得足夠的訂單來充分利用其代工產能,這與台積電(TSM.US)的表現形成鮮明對比。三星及台積電均有望實現2納米製造工藝,相信今次與Tesla的生產協議將被視為對三星製造技術的信心表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.